ArticleBone marrow transplantation2026

Impact of TP53 alterations on outcomes in pediatric and young adult patients with relapsed / refractory B-cell acute lymphoblastic leukemia after CD19-CAR T-Cell therapy.

Anna Alonso-Saladrigues et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.